[Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].

Facteurs prédictifs de l’ostéoradionécrose mandibulaire après irradiation des cancers des voies aérodigestives supérieures.

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 09 2020
revised: 05 03 2021
accepted: 18 03 2021
pubmed: 11 4 2021
medline: 20 7 2021
entrez: 10 4 2021
Statut: ppublish

Résumé

The identification of the different risk factors for mandibular osteoradionecrosis (ORN) must be done before and after the management of patients with head and neck cancer. Various clinical criteria for this severe radiation-induced complication are related to the patient (intrinsic radiosensitivity, malnutrition associated with thin weight loss, active smoking intoxication, microcapillary involvement, precarious oral status, hyposalivation) and/or related to the disease (oral cavity, large tumor size, tumor mandibular invasion). Therapeutic risk factors are also associated with a higher risk of ORN (primary tumor surgery, concomitant radio-chemotherapy, post-irradiation dental avulsion, preventive non-observance with the absence of stomatological follow-up and daily installation of gutters fluoride and, non-observance curative healing treatments). Finally, various dosimetric studies have specified the parameters in order to target the dose values distributed in the mandible, which increases the risk of ORN. An mean mandibular dose greater than 48-54Gy and high percentages of mandibular volume receiving 40 to 60Gy appear to be discriminating in the risk of developing an ORN.

Identifiants

pubmed: 33836955
pii: S1278-3218(21)00049-4
doi: 10.1016/j.canrad.2021.03.002
pii:
doi:

Substances chimiques

Bone Density Conservation Agents 0
Clodronic Acid 0813BZ6866
Tocopherols R0ZB2556P8
Pentoxifylline SD6QCT3TSU

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

484-493

Informations de copyright

Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

F Dutheil (F)

Département d'oncologie radiothérapie du CHU de Limoges, 2, avenue Martin-Luther-King, 87000 Limoges, France; Département d'oncologie radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France.

F Guillemin (F)

Département d'oncologie radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France.

J Biau (J)

Département d'oncologie radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France.

N Pham-Dang (N)

Département de chirurgie maxillo-faciale, CHU Estaing, 1, rue Lucie-Aubrac, 63100 Clermont-Ferrand, France.

N Saroul (N)

Département de chirurgie ORL, CHU Gabriel-Montpied, 58, rue Montalembert, 63000 Clermont-Ferrand, France.

P Clavère (P)

Département d'oncologie radiothérapie du CHU de Limoges, 2, avenue Martin-Luther-King, 87000 Limoges, France.

M Lapeyre (M)

Département d'oncologie radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France. Electronic address: michel.lapeyre@clermont.unicancer.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH